skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Have held this for 18 months ,been very patient as a lot of BNN analysts have liked it with the promise of "unlocking value" when the company splitting into 2 ,but they only thing that has happened really is the stocks "dropping in value" any reason why and your thoughts for the next year on these 2 companies..thanks.
Read Answer Asked by Greg on October 14, 2016
Q: Hi there,

I had two questions. The first one would is on Sleep Country - I noticed that has come off it's highs of around $33ish. Do you think today's price would be a good entry point or will it continue a down trend with profit taking etc?

My second question is on the Balanced Equity portfolio. I have been following your updates and stock selections and started out with a 5% weighting or so in each name. What is the best way to deploy any new funds if I wanted to follow the balanced model? A real world example of this would be if I contribute money into my TSFA next year, what would be the best way to deploy this new cash into the BE Portfolio? Should I divide up the contribution amongst several names? Hold it in cash and wait until you have added a new name to the portfolio and then deploy it? Is there a recommended approach to this?

Thanks!
Read Answer Asked by Michael on October 14, 2016
Q: Enghouse and Allergan have been weak and range bound for some time. Is there a strategy for stocks like this? Does one lower a portfolio weighting once a stock looses momentum? My hesitation has always been that at any time these stocks can report an acquisition and open higher in the double digits. As well, I feel like a hypocrite buying for the long term only to move on when things slow only to look back years later wishing I held. Allergan is a 4% weighting, Enghouse is a 2.5% weighting. Would you consider these core holdings?
Read Answer Asked by John on October 14, 2016
Q: Hi 5i Research team, I just read your recent report on Magna. What would be the impact on Magna revenues and profitability (eps), if tomorrow there were only electric cars produced worldwide? According to you, if the S&P/TSX is trading at a 17x forward eps, at what p/e multiple should Magna trade? Is Magna a stock we buy, put in a drawer and look at a few years later? On a long term basis, in which company (Magna, Linamar, Martinerea, Exco) would you be more comfortable investing in and then leaving for a deserted island for 5 years? Thank you, Eric
Read Answer Asked by Eric on October 14, 2016
Q: I just sold about $5,000.00 in stocks inside my TFSA, with a little profit of $500.00 over the period of 8 months. I did it so I can add it to my self directed RRSP account to lower my taxes this year. In my RRSP I own approx 20% oil,15% financial, 10% utilities, 10% auto, 5% marijuana and the rest is in CDZ. I want to diversify this portfolio. It accounts for 75% of my investments. I am considering a REIT and some technology. What do you recommend?
Read Answer Asked by Grant on October 14, 2016
Q: Hi 5i Research team , I have now limited capital to invest relative to the size of my overall portfolio. I am a long term investor with long horizon and I am relatively satisfied with the quality of the stocks in my portfolio. I have recently mainly used margin, cash from takeover, overweight reductions, dividends over margin's interest and small personal cash contribution to refund the margin used and to make new investments. I am currently fully invested and, I intend to mainly invest in a prepared in advance short list of companies when there is broad stock market corrections (10%ish) that I expected every sx to ten months. Could you comment on this strategy, its merits and weaknesses? Am I forgetting something? Thank you, Eric
Read Answer Asked by Eric on October 14, 2016
Q: Q 2 2016
Net revenues
Net revenues are defined as revenues less direct costs for sub-consultants and other direct expenses
that are recoverable directly from the clients. Net revenues are not an IFRS measure and do not have
a standardized definition within IFRS. Therefore, net revenues may not be comparable to similar
measures presented by other issuers. Investors are advised that net revenues should not be construed
as an alternative to revenues for the period (as determined in accordance with IFRS) as an indicator of
the Corporation’s performance.

For WSP this is a very large number 330 million $ +.. is this typical in the engineering business and is it
variable ? With 34000+ employees why do they need sub-consultants ? and overall
is WSP seriously exposed to wage inflation ?

A lot of questions here, Thank you,

Ian
Read Answer Asked by ian on October 14, 2016
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!